Charles River And Related Sciences Enter Multi-Program Collaboration To Pursue AI-Enabled Drug Discovery Utilizing Logica; Related Sciences To Work With Charles River And Valo Health To Deploy Logica To Discover New Medicines To Address Key Unmet Needs
Portfolio Pulse from Benzinga Newsdesk
Charles River Laboratories (CRL) and Related Sciences have entered into a multi-program collaboration to use AI-enabled drug discovery platform, Logica, to discover new medicines. Logica, a product of Charles River and Valo Health, will be used to discover therapeutics against high-value targets in the Related Sciences portfolio.
September 14, 2023 | 12:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The collaboration between Charles River and Related Sciences to use Logica for drug discovery could potentially lead to new revenue streams for Charles River.
The news of the collaboration is directly related to Charles River, as they are using their product, Logica, for drug discovery. This could potentially lead to the discovery of new drugs, which could in turn lead to new revenue streams for the company. Therefore, this news is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100